Health
Third major COVID-19 vaccine shown to be effective and cheaper – The Australian Financial Review
Early studies show the Oxford vaccine is slightly less effective than the other two – but it does not need special refrigeration and is far cheaper, conditions…
Pfizer and Moderna last week reported preliminary results from late-stage trials showing their vaccines were almost 95 per cent effective. But, unlike its rivals, the AstraZeneca vaccine doesn’t have to be stored at ultra-cold temperatures, making it easier to distribute, especially in developing countries.
The Australian government also has deals with Pfizer and Moderna to potentially deliver 134 million doses of these vaccines at a cost of $3.2 billion.
I think these are really exciting results,…
-
Business6 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Business22 hours agoUS markets swung wildly last night. How extreme volatility can be a gift to ASX investors
-
Noosa News19 hours agoWatch desert floodwaters gushing towards Lake Eyre
-
Noosa News21 hours agoMajor flood arrives at Birdsville